An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments - PubMed (original) (raw)
An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments
Y Fezoui et al. Amyloid. 2000 Sep.
Free article
Abstract
Synthetic amyloid beta-protein (A beta) is used widely to study fibril formation and the physiologic effects of low molecular weight and fibrillar forms of the peptide on cells in culture or in experimental animals. Not infrequently, conflicting results have arisen in these studies, in part due to variation in the starting conformation and assembly state of A beta. To avoid these problems, we sought a simple, reliable means of preparing A beta for experimental use. We found that solvation of synthetic peptide with sodium hydroxide (A beta x NaOH), followed by lyophilization, produced stocks with superior solubility and fibrillogenesis characteristics. Solubilization of the pretreated material with neutral buffers resulted in a pH transition from approximately 10.5 to neutral, avoiding the isoelectric point of A beta (pI approximately 5.5), at which A beta precipitation and aggregation propensity are maximal. Relative to trifluoroacetate (A beta x TFA) or hydrochloric acid (A beta x HCl) salts of A beta, yields of "low molecular weight A beta" (monomers and/or dimers) were improved significantly by NaOH pretreatment. Time-dependent changes in circular dichroism spectra and Congo red dye-binding showed that A beta x NaOH formed fibrils more readily than did the other A beta preparations and that these fibrils were equally neurotoxic. NaOH pretreatment thus offers advantages for the preparation of A beta for biophysical and physiologic studies.
Similar articles
- Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization.
Bozso Z, Penke B, Simon D, Laczkó I, Juhász G, Szegedi V, Kasza A, Soós K, Hetényi A, Wéber E, Tóháti H, Csete M, Zarándi M, Fülöp L. Bozso Z, et al. Peptides. 2010 Feb;31(2):248-56. doi: 10.1016/j.peptides.2009.12.001. Epub 2009 Dec 6. Peptides. 2010. PMID: 19995586 - On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.
Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB. Lomakin A, et al. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1125-9. doi: 10.1073/pnas.93.3.1125. Proc Natl Acad Sci U S A. 1996. PMID: 8577726 Free PMC article. - Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.
Shen CL, Fitzgerald MC, Murphy RM. Shen CL, et al. Biophys J. 1994 Sep;67(3):1238-46. doi: 10.1016/S0006-3495(94)80593-4. Biophys J. 1994. PMID: 7811938 Free PMC article. - Alzheimer's amyloid fibrils: structure and assembly.
Serpell LC. Serpell LC. Biochim Biophys Acta. 2000 Jul 26;1502(1):16-30. doi: 10.1016/s0925-4439(00)00029-6. Biochim Biophys Acta. 2000. PMID: 10899428 Review. - In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N, Klementieva O, Cladera J. Benseny-Cases N, et al. Subcell Biochem. 2012;65:53-74. doi: 10.1007/978-94-007-5416-4_3. Subcell Biochem. 2012. PMID: 23224999 Review.
Cited by
- Optimized experimental pre-treatment strategy for temporary inhibition of islet amyloid polypeptide aggregation.
Ferguson MQ, DeRosa MC. Ferguson MQ, et al. Biochem Biophys Rep. 2021 Apr 10;26:100964. doi: 10.1016/j.bbrep.2021.100964. eCollection 2021 Jul. Biochem Biophys Rep. 2021. PMID: 33912690 Free PMC article. - Development of SERS Active Nanoprobe for Selective Adsorption and Detection of Alzheimer's Disease Biomarkers Based on Molecular Docking.
Garnaik UC, Chandra A, Goel VK, Gulyás B, Padmanabhan P, Agarwal S. Garnaik UC, et al. Int J Nanomedicine. 2024 Aug 14;19:8271-8284. doi: 10.2147/IJN.S446212. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39161360 Free PMC article. - Modulation of aggregate size- and shape-distributions of the amyloid-beta peptide by a designed beta-sheet breaker.
Nagel-Steger L, Demeler B, Meyer-Zaika W, Hochdörffer K, Schrader T, Willbold D. Nagel-Steger L, et al. Eur Biophys J. 2010 Feb;39(3):415-22. doi: 10.1007/s00249-009-0416-2. Epub 2009 Feb 24. Eur Biophys J. 2010. PMID: 19238376 - Oligomeric State and Holding Activity of Hsp60.
Caruso Bavisotto C, Provenzano A, Passantino R, Marino Gammazza A, Cappello F, San Biagio PL, Bulone D. Caruso Bavisotto C, et al. Int J Mol Sci. 2023 Apr 25;24(9):7847. doi: 10.3390/ijms24097847. Int J Mol Sci. 2023. PMID: 37175554 Free PMC article. - Structure-activity relationships of organofluorine inhibitors of β-amyloid self-assembly.
Török B, Sood A, Bag S, Kulkarni A, Borkin D, Lawler E, Dasgupta S, Landge S, Abid M, Zhou W, Foster M, LeVine H 3rd, Török M. Török B, et al. ChemMedChem. 2012 May;7(5):910-9. doi: 10.1002/cmdc.201100569. Epub 2012 Feb 20. ChemMedChem. 2012. PMID: 22351619 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous